SCHEMBL3883801

SCHEMBL3883801

Cc1cc(CCC(=O)O)cc(-c2ccc3[nH]ccc3c2)c1OC1CCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.49
THRB P10828 1/20 0.49
FFAR4 Q5NUL3 8/20 0.45
S1PR1 P21453 2/20 0.43
FFAR1 O14842 3/20 0.40
PTGS2 P35354 1/20 0.40
S1PR3 Q99500 1/20 0.40
S1PR5 Q9H228 1/20 0.40
LMNA P02545 1/20 0.39
PARP10 Q53GL7 1/20 0.39
PARP11 Q9NR21 1/20 0.39
ENPP2 Q13822 1/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36
CHRNA4 P43681 1/20 0.36
CHRNA10 Q9GZZ6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3689125 0.89 THRA (0.47) THRATHRBFFAR4S1PR1PTGS2
SCHEMBL3680532 0.89 THRA (0.48) THRATHRBFFAR4S1PR1FFAR1
SCHEMBL3886848 0.89 FFAR4 (0.48) THRATHRBFFAR4FFAR1PTGS2
SCHEMBL3883630 0.88 THRA (0.50) THRATHRBFFAR4S1PR1FFAR1
SCHEMBL3885488 0.88 THRA (0.50) THRATHRBFFAR4FFAR1PTGS2
SCHEMBL3893900 0.86 THRA (0.45) THRATHRBFFAR4S1PR1FFAR1
SCHEMBL3893894 0.86 THRA (0.45) THRATHRBFFAR4S1PR1FFAR1
SCHEMBL4008909 0.85 THRA (0.47) THRATHRBFFAR4S1PR1FFAR1
SCHEMBL4008911 0.85 THRA (0.47) THRATHRBFFAR4S1PR1FFAR1
SCHEMBL3678537 0.85 FFAR4 (0.50) THRATHRBFFAR4S1PR1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 THRA 1720/4885THRB 3187/4885FFAR4 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.